Cargando…

Mucosal Epithelial Jak Kinases in Health and Diseases

Janus kinases (Jaks) are a family of nonreceptor tyrosine kinase that include four different members, viz., Jak1, Jak2, Jak3, and Tyk2. Jaks play critical roles in immune cells functions; however, recent studies suggest they also play essential roles in nonimmune cell physiology. This review highlig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Narendra, Kuang, Longxiang, Villa, Ryan, Kumar, Priyam, Mishra, Jayshree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990561/ https://www.ncbi.nlm.nih.gov/pubmed/33814980 http://dx.doi.org/10.1155/2021/6618924

Ejemplares similares

Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering
por: Mishra, Jayshree, et al.
Publicado: (2022)

Mechanistic Role of Jak3 in Obesity-Associated Cognitive Impairments
por: Kumar, Premranjan, et al.
Publicado: (2022)

Janus kinase 3 regulates adherens junctions and epithelial mesenchymal transition through β-catenin
por: Mishra, Jayshree, et al.
Publicado: (2017)

JAK-STAT and intestinal mucosal immunology
por: Heneghan, Aaron F, et al.
Publicado: (2013)

JAK Kinases in Health and Disease: An Update
por: Laurence, Arian, et al.
Publicado: (2012)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Contributions of Myosin Light Chain Kinase to Regulation of Epithelial Paracellular Permeability and Mucosal Homeostasis
por: He, Wei-Qi, et al.
Publicado: (2020)

Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders
por: Jain, Mayank, et al.
Publicado: (2022)

The Janus Kinase (JAK) FERM and SH2 Domains: Bringing Specificity to JAK–Receptor Interactions
por: Ferrao, Ryan, et al.
Publicado: (2017)

Oral mucositis
por: Singh, Vibha, et al.
Publicado: (2020)

The Regulation of Intestinal Mucosal Barrier by Myosin Light Chain Kinase/Rho Kinases
por: Jin, Younggeon, et al.
Publicado: (2020)

Jak2 Tyrosine Kinase: A Potential Therapeutic Target for AT(1) Receptor Mediated Cardiovascular Disease
por: Kirabo, Annet, et al.
Publicado: (2010)

JAK Inhibitors in Psoriatic Disease
por: Megna, Matteo, et al.
Publicado: (2023)

The mucosal microbiome in shaping health and disease
por: Pfefferle, Petra Ina, et al.
Publicado: (2014)

To Trap a Pathogen: Neutrophil Extracellular Traps and Their Role in Mucosal Epithelial and Skin Diseases
por: Domínguez-Díaz, Carolina, et al.
Publicado: (2021)

Clinical Aspects of Janus Kinase (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
por: Kotyla, Przemysław J., et al.
Publicado: (2020)

Oral Mucosal Epithelial Cells
por: Groeger, Sabine, et al.
Publicado: (2019)

Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease
por: Martini, Eva, et al.
Publicado: (2017)

Tubulosine selectively inhibits JAK3 signalling by binding to the ATP‐binding site of the kinase of JAK3
por: Kim, Byung‐Hak, et al.
Publicado: (2020)

Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review
por: Wen, Ji, et al.
Publicado: (2021)

Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease
por: McKelvey, Michael C., et al.
Publicado: (2021)

Modulation of epithelial immunity by mucosal fluid
por: Mun, James J., et al.
Publicado: (2011)

Mucosal Antibodies: Defending Epithelial Barriers against HIV-1 Invasion
por: Ruprecht, Ruth M., et al.
Publicado: (2019)

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
por: Degryse, Sandrine, et al.
Publicado: (2015)

Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase
por: Hubbard, Stevan R.
Publicado: (2018)

Under Development JAK Inhibitors for Dermatologic Diseases
por: Sideris, Nikolaos, et al.
Publicado: (2020)

TLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial Pathogens
por: McClure, Ryan, et al.
Publicado: (2014)

Radiation Induced Oral Mucositis
por: PS, Satheesh Kumar, et al.
Publicado: (2009)

Immunohistochemistry of Janus Kinase 1 (JAK1) Expression in Vitiligo
por: Abdou, Asmaa Gaber, et al.
Publicado: (2018)

Signaling by epithelial members of the CEACAM family – mucosal docking sites for pathogenic bacteria
por: Tchoupa, Arnaud Kengmo, et al.
Publicado: (2014)

Novel Therapeutic Options for People with Ulcerative Colitis: An Update on Recent Developments with Janus Kinase (JAK) Inhibitors
por: Troncone, Edoardo, et al.
Publicado: (2020)

Candida albicans Interactions with Mucosal Surfaces during Health and Disease
por: Nikou, Spyridoula-Angeliki, et al.
Publicado: (2019)

Mucosal Immunity to Gut Fungi in Health and Inflammatory Bowel Disease
por: Carlson, Sean L., et al.
Publicado: (2023)

Role of mucosal immunity and epithelial–vascular barrier in modulating gut homeostasis
por: Di Sabatino, Antonio, et al.
Publicado: (2023)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

How Bacteria-Induced Apoptosis of Intestinal Epithelial Cells Contributes to Mucosal Inflammation
por: Hausmann, Martin
Publicado: (2010)

Human mucosal tissue-resident memory T cells in health and disease
por: Lange, Joshua, et al.
Publicado: (2021)

Host/microbiota interactions in health and diseases—Time for mucosal microbiology!
por: Daniel, Noëmie, et al.
Publicado: (2021)

Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
por: Blume-Peytavi, Ulrike, et al.
Publicado: (2015)

Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
por: Furqan, Muhammad, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ugg2ld12gtbs2b6ia32t1tsv0j